Cognizant, a leading provider of consulting, technology and business process outsourcing services, today announced a five-year agreement with AstraZeneca to provide application maintenance services to AstraZeneca's global enterprise in the business-critical areas of research, clinical development, and sales and marketing. The agreement will further expand Cognizant's long-standing relationship with the pharmaceutical major.
Under the expanded agreement, Cognizant will work with AstraZeneca's Global Shared Services organization and implement world class, end-to-end application maintenance services. As part of this innovative agreement, Cognizant will adopt an "Outcome" or "Effect-based" model to provide these services by leveraging its global delivery network, talent pool and best practices. This will ensure a predictable service model, reduce the overall cost of IT ownership, and deliver year-over-year efficiency improvements.
"Our strategic partnerships will enable us to streamline operations efficiency, raise standards and deliver world-class services. The selection of Cognizant will allow us to leverage their global operations to meet the needs of our business and increase our focus on our core business -- to make the most meaningful difference to patient health through great medicines," said
"We are pleased to have been selected by AstraZeneca's global shared services organization to provide application-related services," said Francisco D'Souza, President and CEO of Cognizant. "We look forward to helping AstraZeneca identify and deploy operational improvements in its applications process that will enhance R&D and sales and marketing efficiencies, and help strengthen and extend the company's leadership status in the global life sciences industry.
Posts
No comments:
Post a Comment